Practice Guidance

Drug Development for Upper GI Disorders

Four white papers, developed from the AGA Drug Development Conference, provide updates on drug development for upper GI disorders and help you talk to your patients about participating in clinical trials.

White paper summarizes the presentation and diagnosis of gastroparesis, current treatment options and future plans for drug trials.

In this white paper, experts discuss current status of drug development for EoE and define proper endpoints for future research.

Nimish B. Vakil, MD, AGAF, FASGE, and colleagues summarize current challenges in functional dyspepsia drug development and future directions for patient care and clinical trials.

Expert panel provides recommendations for diagnosis GERD, enrolling patients in trials and future study design.

Patient Companions

Proton pump inhibitors (PPIs) are drugs that are used to lessen the amount of acid made in the stomach.